WallStreetZenWallStreetZen

NASDAQ: CING
Cingulate Inc Stock Ownership - Who owns Cingulate?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cingulate Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas Jeffrey HargrovesDirector2026-02-1397,276$5.04
$490.27kBuy
Matthew BramsEVP and Chief Medical Officer2026-02-061,946$5.04
$9.81kBuy
Jennifer L. CallahanSVP and CFO2026-02-064,864$5.04
$24.51kBuy
Shane J. SchafferChief Executive Officer2026-02-066,809$5.04
$34.32kBuy
Peter J. WerthDirector2026-02-0619,455$5.04
$98.05kBuy

1 of 1

CING insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CING insiders and whales buy or sell their stock.

CING Shareholders

What type of owners hold Cingulate Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Werth Family Investment Associates LLC21.08%2,798,320$15.05MInsider
Fountainhead Shrugged LLC6.08%807,828$4.35MInsider
Vanguard Capital Management LLC2.33%308,967$1.66MInstitution
Craig S. Gilgallon1.47%194,846$1.05MInsider
Gregg Wm Givens1.31%174,318$937.83kInsider
Horn Louis G. Van1.18%156,606$842.54kInsider
Kestra Advisory Services LLC1.05%140,000$753.20kInstitution
Peter J. Werth0.89%117,541$632.37kInsider
Geode Capital Management LLC0.76%101,373$545.39kInstitution
Marshall Wace LLP0.70%92,934$499.98kInstitution

1 of 3

CING vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CING8.95%32.96%Net Buying
MNOV10.98%88.78%
PLRX65.47%34.53%Net Selling
OSTX6.51%14.34%
EXOZ0.46%99.54%Net BuyingNet Selling
View Top Biotech Stocks

Cingulate Stock Ownership FAQ

Who owns Cingulate?

Cingulate (NASDAQ: CING) is owned by 8.95% institutional shareholders, 32.96% Cingulate insiders, and 58.09% retail investors. Werth Family Investment Associates LLC is the largest individual Cingulate shareholder, owning 2.80M shares representing 21.08% of the company. Werth Family Investment Associates LLC's Cingulate shares are currently valued at $14.83M.

If you're new to stock investing, here's how to buy Cingulate stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.